India GLP-1 Receptor Agonist Market Analysis and Trends Indias market for GLP1 receptor agonists is gaining significant momentum, driven by unmet clinical demand, rising awareness, and a steadily expanding healthcare ecosystem
Instead of cutting coverage, which was proposed by the governors veto in July, we were able to come up with this alternative approach to maintain coverage, albeit in a slightly different way, said Erika Scibelli, deputy executive director at the Group Insurance Commission
These figures represent least-squares mean percentage changes from baseline body weight, and the results in the higher-dose groups were statistically significant compared with placebo
This triple-agonist design was not accidental
In rare cases, Accutane can cause more serious side effects, including joint pain, mood changes, or gastrointestinal symptoms